Xerava Effective in Eradicating Organism, Curing cIAIs

Xerava showed similar eradication results as the comparator agents in patients with cIAIs.

DECEMBER 7, 2018

Next-Gen Sequencing Identifies Cause of Febrile Neutropenia in Chemotherapy Patients

Next-gen sequencing might help reduce the amount of antimicrobials given to patients with febrile neutropenia.

NOVEMBER 28, 2018

Protecting Our Borders: Keeping Super Gonorrhea Out

Super gonorrhea has been reported in other countries, and public health and clinicians will have to work together ...

NOVEMBER 19, 2018

Next-Gen Sequencing Identifies Cause of Febrile Neutropenia in Chemotherapy Patients

Next-gen sequencing might help reduce the amount of antimicrobials given to patients with febrile neutropenia.

NOVEMBER 6, 2018

Minnesota RSV Outbreak Traced to New Virus Strain

Researchers found an unusual strain of RSV when they investigated a 2017 outbreak in Minnesota.

OCTOBER 26, 2018

Typhoid Fever Cases Increasing Among U.S. Kids, but Risk Still Low

In the United States, typhoid is primarily a travel related illness, but it is important to be vaccinated if ...

OCTOBER 26, 2018

Biktarvy Demonstrates High Efficacy, Tolerability Through 96 Weeks

Gilead reported 96 week results for a comparative trial of Biktarvy in HIV patients who were treatment naive.

OCTOBER 9, 2018

Delstrigo Demonstrates Long-Term HIV Suppression

Adults with HIV who were switched to the once-daily, fixed-dose Delstrigo combination tablet saw virologic ...

OCTOBER 5, 2018

Switching to Symtuza for HIV Maintains High Virologic Suppression Without Drug Resistance

Adults with HIV who are virologically suppressed maintained that suppression and low virologic failure after ...

OCTOBER 5, 2018

Too Few Teens, Young Adults Who Abuse Opioids Tested for HCV

Only one-third of U.S. adolescents and young adults with opioid use disorder were screened for HCV and only 10% of ...

OCTOBER 5, 2018